ISTH 2021 Congress
Platelet Disorders, von Willebrand Disease and Thrombotic Microangiopathies
Theme Navigation
- ISTH 2021 Congress
- Platelet Disorders, von Willebrand Disease and Thrombotic Microangiopathies
- Acquired Thrombocytopenias
- ADAMTS13 and TTP
- Antiplatelet Therapy
- HIT
- HUS
- Inherited Thrombocytopenias
- Non HUS/TTP Microangiopathies
- Platelet Antagonists and Novel Therapeutics
- Platelet Function Disorders, Acquired
- Platelet Function Disorders, Hereditary
- von Willebrand Factor Biology
- VWF and von Willebrand Factor Disorders - Clinical Conditions
- Platelet Disorders, von Willebrand Disease and Thrombotic Microangiopathies
-
Abstract Number: PB0821
A Multicenter Double-blind, Double-dummy, Randomized Study of rhTPO vs Eltrombopag in the Treatment of Chinese Immune Thrombocytopenia
-
Abstract Number: PB0857
A Multicenter Retrospective Evaluation of Direct Oral Anticoagulants for the Treatment of Heparin Induced Thrombocytopenia
-
Abstract Number: PB0904
A Novel Disease-causing Variant in the GP1BA Gene Related to Bernard Soulier Syndrome
-
Abstract Number: PB0880
A Novel Dual AntiPlatelet and AntiCoagulant APAC: Interaction Between Platelet Factor 4 (PF4) and APAC Decreases Functional Activity
-
Abstract Number: PB0896
A Novel Hemizygous Variant in GATA1 Associated with Bleeding Diathesis and Platelet Dysfunction in Two Unrelated Patients
-
Abstract Number: PB0863
A Puzzling HIT History: HIT Associated with Fondaparinux or True Autoimmune HIT?
-
Abstract Number: PB0933
A Quantitative Evaluation of vWF Multimeric Structure in Patients with Different Types of vWD and aVWS
-
Abstract Number: PO156
A Refractory Thrombotic Thrombocytopenic Purpura Case Complicated by Hepatic Sinusoidal Obstruction Syndrome and Successful Management with Defibrotide
-
Abstract Number: OC 47.2
A Thrombospondin-1 Release Assay (TRA) Coupled to PF4-treated Frozen Platelets is Highly Accurate for the Detection of Pathogenic HIT Antibodies: Implications for Development of a Near-patient HIT in vitro Diagnostic Assay
-
Abstract Number: PB0952
Acquired von Willebrand Disease
-
Abstract Number: PB0938
Acquired von Willebrand Disease: The Diagnosis and Management of an Underdiagnosed Coagulopathy
-
Abstract Number: PB0888
Acquired δ-Storage Pool Disorder Co-existing with Acquired Factor V Deficiency in Myelodysplastic Syndrome / Myeloproliferative Neoplasm
-
Abstract Number: LPB0031
Activity and Cleavage of von Willebrand Disease Type 2B Variants
-
Abstract Number: PB0909
Age-specific Changes in von Willebrand Factor Multimers in Healthy Children and Adults
-
Abstract Number: PB0907
Agglomeration and then Capture within 10 ms Creates Shear-induced Platelet Aggregation Controlled by von Willebrand Factor Concentration
-
Abstract Number: PB0820
Altered Hemostatic Potential in Adults with Primary ITP
-
Abstract Number: OC 53.4
Anti-ADAMTS13 Antibodies in Patients with Hereditary Thrombotic Thrombocytopenic Purpura (hTTP)
-
Abstract Number: OC 66.2
Anti-cysteine/Spacer Autoantibodies that Open the Conformation of ADAMTS13 Are a Common Feature of the Autoimmune Response in Immune-mediated Thrombotic Thrombocytopenic Purpura
-
Abstract Number: PO162
Anti-lymphoma Therapy Improves Thrombocytopenia in a Young Patient with Hodgkin Lymphoma: A Case Report
-
Abstract Number: PB0853
Arginine-containing Peptides and Acetylsalicylic Acid: Evaluation of Antiplatelet Effects
- 1
- 2
- 3
- …
- 10
- Next Page »